Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-10-03
2006-10-03
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S434000, C424S489000, C514S003100, C514S951000
Reexamination Certificate
active
07115561
ABSTRACT:
A medicament powder, system and method for nasal administration of a pharmacologically active peptide across the nasal mucous membrane. A free-flowing powder having a low moisture content includes a cross-linked cation exchange resin in anionic form and a pharmacologically active peptide in cationic form ionically bound together. The particles of the powder function as carriers of the peptide during nasal administration. The cation exchange resin is taken from the group consisting of divinyl benzene cross-linked polystyrene-sulfonates and Na, NH4and K salts thereof. An N-saline solution is sprayed into the nasal cavity after administration of the powder to effect ion exchange of Na in the N-saline with the peptide from the resin for efficient delivery of the peptide.
REFERENCES:
patent: 4153689 (1979-05-01), Hirai et al.
patent: 4613500 (1986-09-01), Suzuki et al.
patent: 5179079 (1993-01-01), Hansen et al.
patent: 5204108 (1993-04-01), Illum
patent: 5578567 (1996-11-01), Cardinaux et al.
patent: 5603943 (1997-02-01), Yanagawa
patent: 5629011 (1997-05-01), Illum
patent: 5648095 (1997-07-01), Illum
patent: 5661130 (1997-08-01), Meezan et al.
patent: 5690954 (1997-11-01), Illum
patent: 5707644 (1998-01-01), Illum
patent: 5725852 (1998-03-01), Igari et al.
patent: 5744166 (1998-04-01), Illum
patent: 5804212 (1998-09-01), Illum
patent: 5908824 (1999-06-01), Yanagawa
patent: 5942242 (1999-08-01), Mizushima et al.
patent: 5948749 (1999-09-01), Igarashi et al.
patent: 5997848 (1999-12-01), Patton et al.
patent: 6197328 (2001-03-01), Yanagawa
patent: 6264975 (2001-07-01), Boucher, Jr.
patent: 6375985 (2002-04-01), Bomberger et al.
patent: 6416742 (2002-07-01), Stefely et al.
patent: 6428780 (2002-08-01), Leone-Bay et al.
patent: 6428805 (2002-08-01), Dohi et al.
patent: 6506730 (2003-01-01), Lee et al.
patent: 6521597 (2003-02-01), Vickery et al.
patent: 6589559 (2003-07-01), Yanagawa
patent: 6699467 (2004-03-01), Leone-Bay et al.
patent: 2002/0012688 (2002-01-01), Dohi et al.
patent: 2004/0063615 (2004-04-01), Oki et al.
patent: 2378001 (2001-11-01), None
Takenaga et al. Microparticle resins as a potential nasal drug delivery system for insulin Journal of Controlled Release 1998, 52, 81-87.
Dow Chemical Company Ion Exchange Media DOWEX.
Arnold Ernst
Prescott Charles J.
Richter Johann
LandOfFree
Medicament composition and method of administration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicament composition and method of administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament composition and method of administration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3670984